GPT and metabolic dysfunction-associated steatotic liver disease: Population-level increases in ALT, AST, and GGT, even within clinically normal limits, have been associated with early hepatic stress, redox imbalance, and the initial stages of metabolic dysfunction and nonalcoholic fatty liver disease [62,63].